iiM - the Innovator
                                                                                                                            Q2 2022 
 
Welcome to The Innovator

Welcome to the Q2 2022 issue of The Innovator, a quarterly newsletter for iiM, LLC. What is iiM? We are a funding platform for early-stage companies in the animal health, agriculture, and human health verticals. In this newsletter, we intend to share educational information, ideas, and a perspective on the investments we are making. If you do not want to receive this publication, please let us know and we will remove you from the list of recipients. Please enjoy this issue of The Innovator.

 

Lydia Kinkade, iiM Managing Director

Advice for Founders in the Current Environment

By R. Lee Harris, iiM Managing Member

Inflation, the war in Ukraine, rising interest rates, and an unsettled political situation have pushed us into a volatile time. What does this mean to the ecosystem for early-stage companies? It’s likely that there may be headwinds of multiple sorts. Supply chain issues could become challenging to start-up companies that are moving into the production stage. This could include raw materials as well as transportation costs and potential snarls. If a company is dependent upon China for any aspect of its operations, this could be problematic. For founders seeking to raise capital, market volatility could result in less favorable terms, longer due diligence time frames and much greater caution on the part of funders. What should a founder do in this current environment?

 

In my opinion, there are three primary areas that should be prioritized by founders. The first is Growth. Growing the business is critical to establishing credibility in the marketplace as well as with investors. This includes acquiring new customers, increasing sales, expanding production facilities, and getting to profitability as soon as possible. If growth has been stagnant the founding team needs to shake things up and figure out how to push the trend line up and to the right. If a company does not yet have revenue, it should attempt to accelerate the process of getting its product into customer hands sooner rather than later. Companies attempting to move through regulatory channels don’t have much choice in terms of timing – does 510(k) approval ring any bells? But there are plenty of steps that a company can take to show growth while awaiting clearance.

 

The second area of focus is Burn. There are too many companies that are extremely vulnerable due to low levels of cash in the bank. I believe that the old advice of raising enough money to have 12 to 18 months of runway should be revised to 18 to 24 months with an emphasis on 24 months. There are numerous ways to manage burn. More companies should take advantage of non-dilutive grants where available to lengthen the runway. Pre-selling product is another possibility. Managing the monthly burn is vital to survival. This can be accomplished by delaying the hiring of non-essential team members, offering deferred compensation in exchange for lower salaries, and being extremely careful with purchasing decisions. Certainly, when raising funds, founders should push the round size to a level that eliminates the need to pass the hat again for 24 months. Bridge rounds between Seed and Series A may become harder to execute and founders should avoid having to constantly be in fundraising mode so they can focus on Growth and managing Burn.

 

Finally, the third priority is that of Margins. Early-stage companies that are not yet profitable need to get there fast. At least be able to show that Gross Margins are headed in the right direction even if the bottom line is in the red. And once profitability is at hand, it’s important to grow Margins on a steady basis. Beware trading large, discounted orders that lower Margins. Sometimes this can be necessary to stay alive, but it’s not a sound long-term strategy. If we’re looking at funding a company and see significant discounting, it’s obvious that the company is simply “buying the business” and really doesn’t prove anything to us in a positive way.

 

Early-stage companies can navigate the choppy waters of the current environment if they have laser-like focus on pushing Growth, managing Burn, and protecting and enhancing Margins. Sooner or later the storm will pass and companies that pay attention to these three factors will emerge stronger than ever.

P&P Optica Seeing Success
Note: P&P Optica is an iiM Portfolio Company

 

Waterloo, Ontario-based P&P Optica (PPO) recently achieved a huge milestone for the company, when it received its first multi-unit order. This order came from a new customer: one of the largest meat and poultry processors in North America. It's another confirmation that their sales efforts are paying off, and that the market is seeing the value of PPO's Smart Imaging System. The  systems are already in process, and the company expects to deliver them later this year. 

 

PPO has developed a Hyperspectral Imaging system that is able to detect contaminants in food at assembly line speeds in food processing operations. With multiple systems operating in poultry and pork plants, the PPO team has started to hear some great stories about the impact their system is having for their clients. They have been able to prevent significant  incidents by finding contaminants – like the one in the photo – for their clients. Another customer reported that they've been able to reduce chargebacks by 40% thanks to PPO's system.       

Green Dot Bioplastics Completes Plant Expansion
Note: Green Dot Bioplastics is an iiM Portfolio Company
Emporia, KS-based Green Dot Bioplastics recently completed construction on the expansion of its plant in Onaga, KS. The expansion to the Onaga facility adds floor space to accommodate additional equipment and warehouse space in order to double production capacity. Production at the facility was able to continue during construction. The project was led by KBS Constructors, leaders in critical environment construction.
 

Green Dot Bioplastics, Inc. is a bioscience social enterprise headquartered in Emporia, Kansas. Celebrating a decade of sustainability, Green Dot is a full-service bioplastics company dedicated to delivering the very best of sustainable materials to our customers. That's the thinking behind the Terratek® line of bioplastics, developed to meet the growing demand for biobased and compostable materials with fewer of the drawbacks associated with traditional plastics.

 
Vytelle Expands Network of Bovine In-Vitro Fertilization Laboratories
March 1, 2022
 
Note: Vytelle is an iiM Portfolio Company

Kansas City, MO – March 1, 2022 – Vytelle is progressing on a five-year plan to provide accessible hormone-free bovine in vitro fertilization (IVF) to producers across the globe. Part of the five-year plan, initiated at the conclusion of their Series A Funding, promised to double the laboratory capacity to produce bovine embryos through in vitro fertilization.

 

Vytelle is a precision livestock company reshaping how cattle producers worldwide optimize their herds, reducing uncertainty to help make mating and reproduction decisions.

 

Why VC Investors Are Plowing Record Sums Into AgTech
February 10, 2022
 
By: Chris Metinko, Crunchbase News

Shifts in how people think about food, investing and even changes brought about by COVID-19 have led to more money—and more deals—in the agtech sector than ever before.

 

Last year was a record year for agtech, with nearly $5 billion invested in the sector in 440 funding deals to VC-backed startups, according to Crunchbase data. That far outstrips the $3.3 billion invested in 422 deals in 2020.

 

 

 

 

A Look at a Portfolio Company

We are pleased to have made 26 investments in 18 companies within the iiM portfolio with due diligence underway for additional investments. One of our more recent portfolio companies is Plastomics, with operations in St. Louis, MO.

 

Plastomics is developing a novel trait delivery technology that places beneficial traits in the chloroplast of plant cells, rather than the nucleus. The chloroplast derives energy from the sun during the process of photosynthesis, enabling higher expression of Plastomics’ traits, increasing their beneficial properties. Plastomics creates crops that can better withstand the pressure of insects, diseases and weeds while delivering higher yields. Using Plastomics’ technology will give seed companies the benefits of simplified product development, more effective products and new market opportunities.

 

Product development is simplified with Plastomics’ trait delivery platform, which allows for precise trait insertion, easy trait stacking and significantly reduced complexity and time in the breeding cycle. With less time required for trait introgression, products are launched faster into the market.

 
iiM made an initial investment in Plastomics for preferred stock in October 2021.

 

https://www.plastomics.com/

About iiM

iiM (Innovation in Motion) is a funding platform for early-stage companies in the Animal Health, Human Health and Agriculture verticals. The company invests $100,000 - $500,000 in selected companies totaling more than $5 million to date. iiM is building a diversified portfolio making 26 investments in 18 companies with commitments to fund at least four more – with a target of at least 30 to 40 portfolio companies. A professional staff guides 37 investors making investments across the United States and Canada.

 

The iiM Syndicate entitles its members to participate in all the iiM meetings and pipeline calls; review prospective investments; view due diligence materials and invest only in those companies that each member chooses. And an investment can be as little as $5,000.

 

Why a syndicate? Syndicate members invest alongside iiM Investor Members to produce a cumulative capital investment that is meaningful to new portfolio companies. Further, if the capital commitment is large enough, iiM may be in a position to lead the investment round and secure even better terms and conditions for all investors. In one investment, Investor and Syndicate members pooled capital totaling $530,000 to invest in a Series A Preferred Stock round. Syndicate members must be Accredited Investors and pay $2,500 per year to participate.

 

If you are interested in attending an iiM meeting or want more information about the iiM Syndicate, please contact Lydia Kinkade, Managing Director, at lkinkade@iimkc.com or (913) 671-3325. The iiM website is www.iimkc.com.

 
 
      A place for entrepreneurs with great ideas.     

www.iimkc.com   |   lkinkade@iimkc.com
View this email in your browser
You are receiving this email because of your relationship with iiM. Please reconfirm your interest in receiving emails from us. If you do not wish to receive any more emails, you can unsubscribe here.

6800 W 64th Street, Suite 101, Overland Park, Kansas, 66202


|